Fistula Closure short‐term · Induction of Remission in Medically Refractory Crohn's Disease
Summary of findings table ‐ Stem Cell may leads to higher fistula Closure short‐term compared with placebo or Control (low certainty).
1 finding from 1 review
Quality of life Short‐Form 36 health survey (SF‐36) · Patients with active Crohn's disease
1 finding from 1 review
Quality of life Short‐Form 36 health survey (SF‐36) · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Short‐term mortality · people with acute pancreatitis
It is very uncertain whether the intervention changes short‐term mortality (very low certainty).
1 finding from 1 review
Complete or partial remission · patients with oesophageal cancer
Active cancer therapy combined with TCM probably leads to higher short‐term therapeutic effects ‐ improvement (complete response +… compared with active cancer therapy (moderate certainty).
1 finding from 1 review
Short‐term therapeutic effects ‐ progressive disease · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in short‐term therapeutic effects ‐ progressive disease compared with active cancer therapy (low certainty).
1 finding from 1 review
Short‐term mortality · people with major upper gastrointestinal, liver and pancreatic surgery
It is very uncertain whether enhanced recovery protocol changes short‐term mortality compared with standard care (very low certainty).
1 finding from 1 review
Intervention not reported
Short‐term mortality · people with necrotising pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term mortality · gastric cancer
Laparoscopic gastrectomy showed no clear difference in short‐term mortality compared with open gastrectomy (low certainty).
1 finding from 1 review
Short‐term mortality (in hospital or within 3 months) · patients with oesophageal cancer
It is very uncertain whether laparoscopic changes short‐term mortality (in hospital or within 3 months) compared with open transhiatal oesophagectomy (very low certainty).
1 finding from 1 review
Short‐term recurrence (within 6 months) · patients with oesophageal cancer
It is very uncertain whether laparoscopic changes short‐term recurrence (within 6 months) compared with open transhiatal oesophagectomy (very low certainty).
1 finding from 1 review
Short‐term mortality · patients with pancreatic cancer
It is very uncertain whether laparoscopic distal pancreatectomy changes short‐term mortality compared with open distal pancreatectomy (very low certainty).
1 finding from 1 review
Intervention not reported
Short‐term mortality · patients with pancreatic pseudocysts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term mortality All‐cause mortality either in‐hospital or within 3 months · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes short‐term mortality All‐cause mortality either in‐hospital or… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Health‐related quality of life Validated self‐reported measures · patients with oesophageal cancer
1 finding from 1 review
Short‐term mortality · people requiring surgery for chronic pancreatitis
It is very uncertain whether duodenum‐preserving pancreatic resection changes short‐term mortality compared with pancreaticoduodenectomy (very low certainty).
1 finding from 1 review
QoL · patients with chronic pancreatitis and pancreatic pain
1 finding from 1 review
Opiate analgesic requirement (short‐term) · patients with chronic pancreatitis and pancreatic pain
1 finding from 1 review
Pain scores (short‐term) · patients with chronic pancreatitis and pancreatic pain
1 finding from 1 review
Intervention not reported
PPI versus placebo Symptomatic outcome measures · patients with heartburn remission in gastro‐oesophageal reflux disease‐like symptoms
The intervention leads to lower PPI versus placebo Symptomatic outcome measures (high certainty).
1 finding from 1 review